Save up -80% on Technetium Tc-99m sestamibi
Note: this is a drug discount program, not an insurance plan.
2018 Price of Technetium Tc-99m sestamibi
* price without discount in nearest pharmacy. Price may vary.
We offer free Technetium Tc-99m sestamibi coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Technetium Tc-99m sestamibi every time. What are you waiting for? Claim your prescription drug card now!
Technetium Tc-99m sestamibi volume of distribution
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Technetium Tc-99m sestamibi
Technetium Tc-99m sestamibi (commonly sestamibi) is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six (sesta=6) methoxyisobutylisonitrile (MIBI) ligands. Following intravenous injection of the drug, Technetium Tc-99m sestamibi is taken up by the myocardium, parathyroid, and/or breast tissue. The mechanism by which sestamibi localizes to these tissues has not been established. Single photon emission computed tomography (SPECT) is then performed to detect the gamma ray emmitted by the decay of Technetium-99m to Technetium-99. Currently available within a preparation kit for injection, Technetium Tc 99m Sestamibi is indicated for: 1) detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects); and 2) evaluating myocardial function and developing information for use in patient management decisions.
Technetium Tc-99m sestamibi mechanism of action
Dosage forms of Technetium Tc-99m sestamibi
|Injection, powder, lyophilized, for solution||intravenous||1 mg/mL|
|Injection, powder, lyophilized, for solution||parenteral||1 mg/5mL|
99m Tc-sestamibi 99m-Tc sestamibi
Lantheus Medical Imaging, Inc.
Indication of Technetium Tc-99m sestamibi
Technetium Tc 99m Sestamibi is indicated for: 1) detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects); and 2) evaluating myocardial function and developing information for use in patient management decisions.
Toxicity of Technetium Tc-99m sestamibi
The following adverse reactions have been reported in 0.5% of patients: signs and symptoms consistent with seizure occurring shortly after administration of the agent; transient arthritis; angioedema, arrhythmia, dizziness, syncope, abdominal pain, vomiting, and severe hypersensitivity characterized by dyspnea, hypotension, bradycardia, asthenia, and vomiting within two hours after a second injection of Technetium Tc 99m Sestamibi. A few cases of flushing, edema, injection site inflammation, dry mouth, fever, pruritis, rash, urticaria and fatigue have also been attributed to administration of the agent.
RX24 Drugs Disclaimer: before buying a Technetium Tc-99m sestamibi on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.